Havekes LM - Search Results

1

Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease.

van Duijn CM, de Knijff P, Cruts M, Wehnert A, Havekes LM, Hofman A, Van Broeckhoven C. van Duijn CM, et al. Among authors: havekes lm. Nat Genet. 1994 May;7(1):74-8. doi: 10.1038/ng0594-74. Nat Genet. 1994. PMID: 8075646

2

Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease.

van Duijn CM, Havekes LM, Van Broeckhoven C, de Knijff P, Hofman A. van Duijn CM, et al. Among authors: havekes lm. BMJ. 1995 Mar 11;310(6980):627-31. doi: 10.1136/bmj.310.6980.627. BMJ. 1995. PMID: 7703749 Free PMC article.

3

The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival.

van Duijn CM, de Knijff P, Wehnert A, De Voecht J, Bronzova JB, Havekes LM, Hofman A, Van Broeckhoven C. van Duijn CM, et al. Among authors: havekes lm. Ann Neurol. 1995 May;37(5):605-10. doi: 10.1002/ana.410370510. Ann Neurol. 1995. PMID: 7755355

4

Apolipoprotein e4 allele and cognitive decline in elderly men.

Feskens EJ, Havekes LM, Kalmijn S, de Knijff P, Launer LJ, Kromhout D. Feskens EJ, et al. Among authors: havekes lm. BMJ. 1994 Nov 5;309(6963):1202-6. doi: 10.1136/bmj.309.6963.1202. BMJ. 1994. PMID: 7987151 Free PMC article.

5

Apolipoprotein E genotype and concomitant clinical features in early-onset Alzheimer's disease.

Bronzova J, van Duijn CM, Havekes LM, de Knijff P, Van Broeckhoven C, Hofman A. Bronzova J, et al. Among authors: havekes lm. J Neurol. 1996 Jun;243(6):465-8. doi: 10.1007/BF00900501. J Neurol. 1996. PMID: 8803820

6

Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study.

Slooter AJ, de Knijff P, Hofman A, Cruts M, Breteler MM, Van Broeckhoven C, Havekes LM, van Duijn CM. Slooter AJ, et al. Among authors: havekes lm. Neurosci Lett. 1998 May 22;248(1):21-4. doi: 10.1016/s0304-3940(98)00339-5. Neurosci Lett. 1998. PMID: 9665654

7

Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam Study.

Slooter AJ, van Duijn CM, Bots ML, Ott A, Breteler MB, De Voecht J, Wehnert A, de Knijff P, Havekes LM, Grobbee DE, Van Broeckhoven C, Hofman A. Slooter AJ, et al. Among authors: havekes lm. J Neural Transm Suppl. 1998;53:17-29. doi: 10.1007/978-3-7091-6467-9_3. J Neural Transm Suppl. 1998. PMID: 9700643 Clinical Trial.

8

Apolipoprotein E and carotid artery atherosclerosis: the Rotterdam study.

Slooter AJ, Bots ML, Havekes LM, del Sol AI, Cruts M, Grobbee DE, Hofman A, Van Broeckhoven C, Witteman JC, van Duijn CM. Slooter AJ, et al. Among authors: havekes lm. Stroke. 2001 Sep;32(9):1947-52. doi: 10.1161/hs0901.095377. Stroke. 2001. PMID: 11546879

9

Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study.

Roks G, Cruts M, Houwing-Duistermaat JJ, Dermaut B, Serneels S, Havekes LM, Hofman A, Breteler MM, Van Broeckhoven C, van Duijn CM. Roks G, et al. Among authors: havekes lm. Am J Med Genet. 2002 Jul 8;114(5):570-3. doi: 10.1002/ajmg.10407. Am J Med Genet. 2002. PMID: 12116196

10

Apolipoprotein E polymorphism in The Netherlands and its effect on plasma lipid and apolipoprotein levels.

Smit M, de Knijff P, Rosseneu M, Bury J, Klasen E, Frants R, Havekes L. Smit M, et al. Hum Genet. 1988 Nov;80(3):287-92. doi: 10.1007/BF01790099. Hum Genet. 1988. PMID: 3192216

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

448 results

Search Page